Literature DB >> 22903166

Influence of age, social patterns and nasopharyngeal carriage on antibodies to three conserved pneumococcal surface proteins (PhtD, PcpA and PrtA) in healthy young children.

A Hagerman1, K M Posfay-Barbe, S Grillet, M M Ochs, R H Brookes, D Greenberg, N Givon-Lavi, R Dagan, C-A Siegrist.   

Abstract

The acquisition of specific antibodies is paramount to protect children against pneumococcal diseases, and a better understanding of how age, ethnicity and/or Streptococcus pneumoniae (Spn) nasopharyngeal carriage influence the acquisition of antibodies to pneumococcal surface proteins (PSP) is important for the development of novel serodiagnostic and immunisation strategies. IgG antibody titres against three conserved PSP (PhtD, PcpA and PrtA) in the sera of 451 healthy children aged 1 to 24 months from Israel [Jewish (50.1 %) and Bedouin (49.9 %)] were measured by enzyme-linked immunosorbent assay (ELISA), while nasopharyngeal swabs from these children were assessed for the presence of Spn. Globally, anti-PhtD and anti-PrtA geometric mean concentrations (GMC; EU/ml) were high at <2.5 months of age [PhtD: 35.3, 95 % confidence interval (CI) 30.6-40.6; PrtA: 71.2, 95 % CI 60-84.5], was lower at 5-7 months of age (PhtD: 10, 95 % CI 8-12.4; PrtA: 17.9, 95 % CI 14.4-22.1) and only increased after 11 months of age. In contrast, an increase in anti-PcpA was observed at 5-7 months of age. Anti-PcpA and anti-PrtA, but not anti-PhtD, were significantly higher in Bedouin children (PcpA: 361.6 vs. 226.3, p = 0.02; PrtA: 67.2 vs. 29.5, p < 0.001) in whom Spn nasopharyngeal carriage was identified earlier (60 % vs. 38 % of carriers <6 months of age, p = 0.002). Spn carriage was associated with significantly higher anti-PSP concentrations in carriers than in non-carriers (p < 0.001 for each PSP). Thus, age, ethnicity and, essentially, nasopharyngeal carriage exert distinct cumulative influences on infant responses to PSP. These specific characteristics are worthwhile to include in the evaluation of pneumococcal seroresponses and the development of new PSP-based vaccines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22903166     DOI: 10.1007/s10096-012-1712-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  27 in total

1.  Pneumococcal surface adhesin A antibody concentration in serum and nasopharyngeal carriage of Streptococcus pneumoniae in young African infants.

Authors:  S K Obaro; R A Adegbola; J A Tharpe; E W Ades; K P McAdam; G Carlone; J S Sampson
Journal:  Vaccine       Date:  2000-10-15       Impact factor: 3.641

2.  Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage.

Authors:  Emma Holmlund; Beatriz Quiambao; Jukka Ollgren; Hanna Nohynek; Helena Käyhty
Journal:  Vaccine       Date:  2005-08-03       Impact factor: 3.641

3.  Mn2+-dependent regulation of multiple genes in Streptococcus pneumoniae through PsaR and the resultant impact on virulence.

Authors:  Jason W Johnston; David E Briles; Lisa E Myers; Susan K Hollingshead
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

4.  Immunity to pneumococcal surface proteins in children with community-acquired pneumonia: a distinct pattern of responses to pneumococcal choline-binding protein A.

Authors:  K M Posfay-Barbe; A Galetto-Lacour; S Grillet; M M Ochs; R H Brookes; J D Kraehenbuhl; M Cevey-Macherel; M Gehri; A Gervaix; C-A Siegrist
Journal:  Clin Microbiol Infect       Date:  2010-12-17       Impact factor: 8.067

5.  Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.

Authors:  Carrie L Byington; Matthew H Samore; Gregory J Stoddard; Steve Barlow; Judy Daly; Kent Korgenski; Sean Firth; David Glover; Jasmin Jensen; Edward O Mason; Cheryl K Shutt; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2005-05-26       Impact factor: 9.079

6.  Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media.

Authors:  S Rapola; V Jäntti; R Haikala; R Syrjänen; G M Carlone; J S Sampson; D E Briles; J C Paton; A K Takala; T M Kilpi; H Käyhty
Journal:  J Infect Dis       Date:  2000-09-05       Impact factor: 5.226

7.  Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization.

Authors:  Tera L McCool; Thomas R Cate; Elaine I Tuomanen; Peter Adrian; Tim J Mitchell; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

8.  Development of antibodies against the putative proteinase maturation protein A in relation to pneumococcal carriage and otitis media.

Authors:  Debby Bogaert; Emma Holmlund; Mika Lahdenkari; Ronald de Groot; Terhi Kilpi; Peter W M Hermans; Helena Kayhty
Journal:  FEMS Immunol Med Microbiol       Date:  2006-03

9.  Immune response to capsular polysaccharide and surface proteins of Streptococcus pneumoniae in patients with invasive pneumococcal disease.

Authors:  Gregor Zysk; Gesina Bethe; Roland Nau; Daniela Koch; Valeska C D H Gräfin Von Bassewitz; Hans-Peter Heinz; Ralf R Reinert
Journal:  J Infect Dis       Date:  2002-12-19       Impact factor: 5.226

10.  Longitudinal study on pneumococcal carriage during the first year of life in Bangladesh.

Authors:  Simo M Granat; Zakaria Mia; Jukka Ollgren; Elja Herva; Milan Das; Liisa Piirainen; Kari Auranen; P Helena Mäkelä
Journal:  Pediatr Infect Dis J       Date:  2007-04       Impact factor: 2.129

View more
  3 in total

1.  Surface association of Pht proteins of Streptococcus pneumoniae.

Authors:  Charles D Plumptre; Abiodun D Ogunniyi; James C Paton
Journal:  Infect Immun       Date:  2013-07-22       Impact factor: 3.441

2.  Streptococcus pneumoniae Cell-Wall-Localized Phosphoenolpyruvate Protein Phosphotransferase Can Function as an Adhesin: Identification of Its Host Target Molecules and Evaluation of Its Potential as a Vaccine.

Authors:  Yaffa Mizrachi Nebenzahl; Karin Blau; Tatyana Kushnir; Marilou Shagan; Maxim Portnoi; Aviad Cohen; Shalhevet Azriel; Itai Malka; Asad Adawi; Daniel Kafka; Shahar Dotan; Gali Guterman; Shany Troib; Tali Fishilevich; Jonathan M Gershoni; Alex Braiman; Andrea M Mitchell; Timothy J Mitchell; Nurith Porat; Inna Goliand; Vered Chalifa Caspi; Edwin Swiatlo; Michael Tal; Ronald Ellis; Natalie Elia; Ron Dagan
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

3.  PrtA immunization fails to protect against pulmonary and invasive infection by Streptococcus pneumoniae.

Authors:  Chen-Fang Hsu; Chen-Hao Hsiao; Shun-Fu Tseng; Jian-Ru Chen; Yu-Jou Liao; Sy-Jou Chen; Chin-Sheng Lin; Huey-Kang Sytwu; Yi-Ping Chuang
Journal:  Respir Res       Date:  2018-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.